Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate [version 2; peer review: 2 approved]

Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate [version 2; peer review: 2 approved]

Background: This study aims to determine the factors affecting HBV DNA suppression in chronic hepatitis B patients with tenofovir disoproxil fumarate (TDF). Methods: A case-control was carried out from October 2021 to August 2022 on 182 chronic hepatitis B patients who had TDF therapy regularly for...

Full description

Bibliographic Details
Main Authors: Putri Chairani Eyanoer, Masrul Lubis, Mustafa Mahmud Amin, Fauzi Yusuf, Tri Widyawati, Muhammad Rusda, Dharma Lindarto, Jelita Siregar, Imelda Rey, Darmadi Darmadi
Format: Article
Language:English
Published: F1000 Research Ltd 2023-08-01
Series:F1000Research
Subjects:
CTLA-4
HBV DNA
Hepatitis B
Polymorphism
Tenofovir
eng
Online Access:https://f1000research.com/articles/11-1521/v2

Internet

https://f1000research.com/articles/11-1521/v2

Similar Items